Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €27.75 EUR
Change Today -0.213 / -0.76%
Volume 0.0
As of 2:10 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

olympus corp (OLY1) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/5/15 - €35.93
52 Week Low
10/17/14 - €25.23
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OLYMPUS CORP (OLY1)

Related News

No related news articles were found.

olympus corp (OLY1) Related Businessweek News

View More BusinessWeek News

olympus corp (OLY1) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

31,540 Employees
Last Reported Date: 06/26/15
Founded in 1919

olympus corp (OLY1) Top Compensated Officers

President and Representative Director
Total Annual Compensation: ¥98.6M
Compensation as of Fiscal Year 2015.

olympus corp (OLY1) Key Developments

Olympus Launches Dualknifej Single-Use Electrosurgical Knife in Japan

Olympus Corporation has announced the launch of the DualKnifeJ single-use electrosurgical knife in Japan in fall 2015. It will become available in a global rollout to other markets as the relevant requirements are satisfied (declaration of conformity, product registration, or market clearance). The knife is designed for use in ESD, an advanced technique of therapeutic endoscopy that allows for en bloc removal of early stage tumors that have not entered the muscle layer in the stomach, esophagus, colon, and other parts of the gastrointestinal tract. The knife has been equipped with a new fluid injection function to facilitate shorter procedure times and accurate ESD. In addition to maintaining the same underlying performance in existing incision and dissection techniques, the knife also has a function that physicians can use to inject saline into exposed submucosal layers without the need to swap instruments during procedure. ESD injects saline or other fluid into the submucosal layer below cancerous tissue to raise it up so that it can be incised and dissected by the knife. Sometimes, however, fluid injected at the start of the procedure can leak out over time. The new knife includes a fluid injection function that physicians can use to inject fluid into the submucosal layer as often as needed without having to swap the device each time. This helps shorten procedure times and enable more accurate ESD by making it easy to recognize the tissue to be removed and facilitating Incision and dissection. Olympus is considering this injection function for future product launches as well.

Olympus Corporation Announces Launch of its New Z Drift Compensator IX3-ZDC2 for More Efficient Imaging on the Inverted Research Microscope IX83

Olympus Corporation announced the progressive international launch by its Scientific Solutions Business of its new Z Drift Compensator IX3-ZDC2 for more efficient imaging on the inverted research microscope IX83, and the new imaging software cellSens v1.14 of its for biological microscopes, commencing on October 1, 2015. The IX3 Series of inverted research microscopes (IX83, IX73, and IX53) are designed to support live cell imaging for the observation of living cells. In addition to the excellent performance of the microscope itself, they also feature a high expandability to meet various requirements, such as switchover among observation methods or image capturing, through the addition of various application-specific functions or units. The new IX3-ZDC2 unit is for the IX83. Used in conjunction with the cellSens v1.14, it offers live cell imaging with microplates and provides a more efficient and seamless workflow all the way from image capture to measurement, analysis, and report creation. Keeps the acquired images sharp and focused by continuously detecting the distance between the objective lens and sample container. The use of near-infra-red light with low phototoxicity for focusing minimizes damage to cells, meaning that time-lapse imaging can be used to observe the changes in cells over a long period of time. A single plate that contains a large number of equal-sized wells spaced at regular intervals. Plates are available in a variety of configurations (with 6, 24, or 96 wells, for example), and are useful for the simultaneous culturing and observation of multiple cells, such as comparing reactions to different agents. In the fields of regenerative medicine and drug discovery different types of cells including iPS and other stem cells are produced for research use through a continuous culturing process. Microplates are a common container used for this purpose. Through improvement of its internal optics, the IX3-ZDC2 is able to perform rapid focusing and complete high-speed imaging in approximately two minutes for a 96-well microplate. This enables the efficient imaging of a large number of wells. In addition to glass bottom dishes, the IX3-ZDC2 also supports the use of plastic bottom dishes, which provides excellent cost-performance in a wide range of uses. Consecutive imaging of 96 locations (one image per well) in a glass bottom microplate. cellSens v1.14: Dedicated database provides efficient viewing and analysis of large amounts of image data The cellSens v1.14 imaging software designed for use with the IX3-ZDC2 uses a dedicated database to provide functions such as displaying thumbnails for quick viewing of the captured images and the one-click search and analysis of specific images. These functions enable the efficient viewing and analysis of large amounts of data.

Advanced Microscopy Inc. Enters into Patent License Agreement with Olympus Corporation

WiLAN has announced that its subsidiary, Advanced Microscopy Inc. has entered into a patent license agreement with Olympus Corporation. The license relates to technology that provides enhanced image processing capabilities. It has potential applications including, but not limited to, life sciences, material sciences, and semiconductor research. This is the second license WiLAN has secured to this portfolio since its acquisition. Under its licensing partnership model, WiLAN typically offers little to no upfront payment to acquire portfolios. Patent vendors receive all or most of their compensation once WiLAN has successfully licensed the relevant portfolio. The license resolves litigation pending in the District of Delaware. The settlement and terms of the license agreement are confidential.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OLY1:GR €27.75 EUR -0.213

OLY1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $55.78 USD -0.24
Avery Dennison Corp $59.49 USD -0.12
Nikon Corp ¥1,578 JPY +8.00
Smith & Nephew PLC 1,124 GBp +1.00
Terumo Corp ¥3,340 JPY -15.00
View Industry Companies

Industry Analysis


Industry Average

Valuation OLY1 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.7x
Price/Book 3.5x
Price/Cash Flow 34.3x
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OLYMPUS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at